Back to search
A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Hematological Malignancies
Clinicaltrials.gov:
EU CTIS:
#2023-503438-40-00
EudraCT:
J&J ID:
#CR108859
Other:
#TECLIMMY1001-P3
Other:
#2023
Other:
#2016
Subscribe or share this trial
Trials at a glance
Status
Enrollment complete
Condition
Hematological Malignancies
Trial type
Interventional
Trial phase
Phase 2
Investigational
product
product
Teclistamab
Age
18+ years old
Biological sex
All
Placebo?
No
Trial start date
September 17, 2020
Trial end date
May 28, 2027
CT.gov ID
#NCT04557098
Countries:
- Belgium,
- Canada,
- China,
- France,
- Germany,
- Italy,
- Netherlands,
- Spain,
- Sweden,
- United Kingdom,
- United States
Loading...
Calgary, Alberta, Canada, T2N 5G2
Bergamo, Italy, 24127
Detroit, Michigan, United States, 48201
Nantes, France, 44093
Tours, France, 37044
Poitiers, France, 86000
Lyon, France, 69002
Lille, France, 59000
Duarte, California, United States, 91010
Pamplona, Spain, 31008
Edmonton, Alberta, Canada, T6G 1Z2
Hangzhou, China, 310003
Milan, Italy, 20133
Stockholm, Sweden, SE-141 86
Barcelona, Spain, 08036
Salamanca, Spain, 37007
Pozuelo de Alarcón, Spain, 28223
Madrid, Spain, 28041
Badalona, Spain, 08916
Santander, Spain, 39008
New York, New York, United States, 10029
Bologna, Italy, 40138
Charlotte, North Carolina, United States, 28204
Montreal, Quebec, Canada, H4A 3J1
New York, New York, United States, 10065
Beijing, China, 100034
Toulouse, France, 31059
Sutton, United Kingdom, SM2 5PT
Gothenburg, Sweden, 413 45
Shanghai, China, 200003
Shenyang, China, 110134
Lund, Sweden, 221 85
Stanford, California, United States, 94305-5623
Guangzhou, China, 510060
Xi'an, China, 710004
Tianjin, China, 30060
Heidelberg, Germany, 69120
Leipzig, Germany, 04103
Tübingen, Germany, 72076
Ghent, Belgium, 9000
Leuven, Belgium, 3000
Würzburg, Germany, 97080
London, United Kingdom, NW1 2PG
Toronto, Ontario, Canada, M5G 2M9
Sothampton, United Kingdom, SO16 6YD
Birmingham, Alabama, United States, 35294
San Francisco, California, United States, 94143
Philadelphia, Pennsylvania, United States, 19104
Amsterdam, Netherlands, 1081 HV
Chengdu, China, 610041
Atlanta, Georgia, United States, 30322
#
More than 50 sites in this region
#
More than 10 sites in this region
#
Less than 10 sites in this region
Individual sites
Access detailed information on the trial:
Clinical trials information
Key links
© Johnson & Johnson and its affiliates 2026
